The CD123 antibody-drug conjugate pivekimab sunirine exerts profound activity in preclinical models of pediatric acute lymphoblastic leukemia. - Watts B; Smith CM; Evans K; Gifford AJ; Mohamed SMA; Erickson SW; Earley EJ; Neuhauser S; Stearns TM; Philip VM; Chuang JH; Zweidler-McKay PA; et al. (HemaSphere, 2025)